ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
다우존스 지수
38,686.32
1.51%
Bitcoin
68,110.97
0.57%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Genaissance Pharmaceuticals (MM) (GNSC)

  7. Genaissance Pharmaceuticals (MM) (GNSC) 뉴스

GNSC

Genaissance (GNSC)

Genaissance Pharmaceuticals (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:GNSC
일자시간출처헤드라인심볼기업
2005/10/0321:00PR Newswire (US)Genaissance Enters into HAP(TM) Technology License Agreement with SankyoNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/09/2121:00PR Newswire (US)Genaissance Enters Pharmacogenomic Collaboration with OtsukaNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/09/1221:00PR Newswire (US)Genaissance Pharmaceuticals and Ipsogen Announce Cancer Biomarker Research AgreementsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/08/2321:30PR Newswire (US)Genaissance Will Provide Genotyping Services for Cyprus Scrapie ContractNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/08/1121:30PR Newswire (US)Genaissance Will Provide Exclusive Genotyping Services for Greek Scrapie ContractNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/07/1821:30PR Newswire (US)Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with OrganonNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/06/2121:15PR Newswire (US)Clinical Data to Acquire Genaissance PharmaceuticalsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/06/2120:15Business WireClinical Data to Acquire Genaissance Pharmaceuticals; Combined Company to Deliver Industry-Defining TheranosticsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/06/0721:30PR Newswire (US)Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO PartnerNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/05/0321:30PR Newswire (US)Genaissance Reports First Quarter 2005 ResultsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/04/2905:23PR Newswire (US)Genaissance Pharmaceuticals Comments on Stock ActivityNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/04/2800:00PR Newswire (US)Genaissance Pharmaceuticals to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare ConferenceNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/04/2700:00PR Newswire (US)Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2005 Conference CallNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/04/2221:31PR Newswire (US)Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt FinancingNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/04/2221:30PR Newswire (US)Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt FinancingNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/04/0621:32PR Newswire (US)Genaissance and ParAllele BioScience Sign License and Co-Marketing AgreementNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/04/0101:30PR Newswire (US)Genaissance Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals ConferenceNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/03/2302:00PR Newswire (US)Genaissance Comments on FDA Guidance on PharmacogenomicsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/03/1121:30PR Newswire (US)Genaissance Allowed Patent for Method of Testing Individuals for Genetic Predisposition to Reduced Metabolism of DrugsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/03/0922:00PR Newswire (US)Genaissance and Monsanto Company Team Up with the USDA to Map Soybean GenomeNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/03/0922:00PR Newswire (US)Genaissance and Monsanto Company Team Up With the USDA to Map Soybean GenomeNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/02/1521:30PR Newswire (US)Genaissance Pharmaceuticals' New DNA Test - FAMILION(TM) - Becoming Key Tool for Detecting Long QT Syndrome, a Potentially FatalNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/02/1023:00PR Newswire (US)Genaissance Pharmaceuticals Reports 2004 ResultsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/02/0400:00PR Newswire (US)Genaissance Pharmaceuticals, Inc. Invites You to Participate in its Fourth Quarter 2004 Conference CallNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/01/2621:30PR Newswire (US)Genaissance Obtains License to Vanderbilt Patent Linking Genetics to Key Drug Safety IssueNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/01/2421:30PR Newswire (US)Genaissance Study Sheds Light on Mechanism of Heart Disease Risk by Linking Genetic Variation to the Effect of Hormone ReplacemeNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2005/01/0421:30PR Newswire (US)Genaissance Allowed Patent for Novel Methods to Correlate Genetics With Drug Safety and EfficacyNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2004/12/2021:30PR Newswire (US)Genaissance Identifies Genetic Markers Implicated in Fatal Side Effects Of Schizophrenia DrugNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2004/12/0221:00PR Newswire (US)Genaissance Pharmaceuticals Signs Research Agreement With Sygen InternationalNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
2004/11/1922:56PR Newswire (US)Genaissance to Raise Approximately $6 Million in Private PlacementNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
 검색 관련기사 보기:NASDAQ:GNSC

최근 히스토리

NASDAQ
TSLA
Tesla
NASDAQ
AAPL
Apple
CCOM
SILVER
SILVER
NYSE
CVX
Chevron
CCOM
US500
US 500
NASDAQ
NVDA
NVIDIA
AMEX
XLF
Financial Select Sector
USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLE
Energy Select Sector SPDR
USI
USTECH100
US Tech 100
NYSE
MCD
McDonalds
COIN
ETHUSD
Ethereum
NASDAQ
AMZN
Amazon.com
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유